Our funds are used, in the main, for education for members, including study days and the VOICE course, and attending conferences and meetings. We have been fortunate in that so far all our
speakers and meeting organisers have donated their time and the costs incurred were put to ensuring volunteers are able to attend.
Our income since we began has come from a variety of sources, including pharmaceutical companies (35%), members’ fundraising (13%), health charities (20%) academia (19%),and fees charged (7%). We are aware that we need to remain independent of pharmaceutical companies. However, it is in the interest of all cancer patients that effective drugs are developed, and we feel that donations from pharmaceutical companies are therefore appropriate.
We believe that it is important for researchers to budget for lay input to new trials when making funding applications and we aim to recoup some of our costs in this way; this is needed to enable the participation of some members.
Members and trustees receive no payment from ICPV, except travel expenses and generously donate their time and expertise.
For more detailed information on our accounts please contact the Treasurer.
There are a number of ways to donate to ICPV
PayPal Giving Fund
Make donations PayPal Account
You can send eCards for any occasion and donate to ICPV.
Go to https://www.dontsendmeacard.com/charities/ and search for Independent Cancer Patients' Voice
Easyfundraising is the simplest way to raise funds for ICPV. You shop online with your favourite stores and you raise money at the same time. It's that easy.
Easy Fundraising work with thousands of well known retailers including John Lewis, eBay, Amazon, M&S, Argos, and many more. The retailers will donate a percentage of your spend to your cause when you shop with them through the easyfundraising site.
Just go to Easyfundraising and register.
We are pleased to announce that the VOICE course will be residential and held at Barts Cancer Centre from 4-8 Sept. Click here for further details.
OPTIMA is a patient driven clinical study for people with hormone sensitive early breast cancer.
On the 25th March we held an interactive talk and discussion on immunology.
The talk was given by Dr Edd James, Cancer Immunologist from the university of Southampton. The tallk is now available on YouTube - click here to listen.
Long Term Survivor Study
Continuum Life Sciences are looking for volunteers who have survived aggressive, difficult to treat cancer against all odds to take part in their Long-Term Survivor of Cancer Study. For more information and how you can join go to their website.
Save the planet and donate to ICPV - send ecards go tour Fundraising page for mor information.
FAST-Forward Trial Results
A one-week course of radiotherapy in fewer but larger daily doses was found to be as safe and effective as standard three-week therapy for women following surgery for early stage breast cancer. Trial results now published. Two ICPV members provided the PPI for this key trial. Full details can be found on the ICR Website.
ICPV Brighton Summer School Aug 2019
ICPV was once again hosted by SHORE-C at the University of Sussex. Click here for more info.
San Antonio Breast Cancer Symposium, 2018
ICPV member Pat Fairbrother attended this event on an Alamo Foundation Scholarship. Click here to read her review.
Gap Analysis in Breast Surgery Published
The 2013 Breast Cancer Campaign gap analysis established breast cancer research priorities without a specific focus on surgical research or the role of surgeons on breast cancer research. This Review aims to identify opportunities and priorities for research in breast surgery to complement the 2013 gap analysis. Click here for more information
ICPV Review 2018
We have at last published a new edition of our review. This was achieved by a grant from Novartis. Click here for more information.
Award for ICPV Member
Many congratulations to ICPV member Margaret Grayson. On 21 April 2018 she received the Iris Colvin Lifetime Achievement Award for Health, presented by the Women’s Forum of Northern Ireland. This is very well deserved for her tireless work in furthering cancer research especially in Northern Ireland.